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ABSTRACT 
ERIN MCMULLEN: Predicting maximum oxygen uptake (VO2max) using a dynamical systems 
model in acute myeloid leukemia patients. 
(Under the direction of Claudio Battaglini) 
 
PURPOSE: To determine if a dynamical systems model can estimate VO2max using data from a 
CPET on a cycle ergometer in acute leukemia patients prior to treatment. METHODS: Seventeen 
patients performed a CPET. The VO2peak obtained during the CPET and predicted values from 
the dynamical systems model were compared using paired samples t-tests. RESULTS: 
Significant differences between VO2peak obtained during the CPET ((18.09 ± 4.89) p=.001) and 
dynamical systems prediction (22.45 ± 7.00 mL/kg/min) was observed. A significant correlation 
between the predicted and obtained values for the time series was observed (r (16) = 0.96 p 
<.05), while the model had a percent error of 25%. CONCLUSION: Since transient changes 
captured in VO2 in response to the demands placed on the equilibria of the dynamical system, the 
system is not subject to the same physiological CPET limitations, potentially providing a more 
precise VO2max determination.   
 
 
 
 
 
 
 iv 
TABLE OF CONTENTS 
LIST OF TABLES .................................................................................................................vii 
CHAPTER ONE: INTRODUCTION ....................................................................................1 
Background ................................................................................................................1 
Statement of Purpose .................................................................................................6 
Research Question .....................................................................................................6 
Hypothesis..................................................................................................................6 
Definition of Terms ....................................................................................................7 
Assumptions ...............................................................................................................8 
Limitations .................................................................................................................8 
Delimitations ..............................................................................................................8 
Significance ................................................................................................................8 
CHAPTER TWO: REVIEW OF LITERATURE ..................................................................10 
Cardiopulmonary Exercise Testing ............................................................................10 
Prognostic Value Of VO2 ...........................................................................................11 
Current Issues with Cardiopulmonary Testing ..........................................................13 
Non-exercise VO2 Prediction Equations ....................................................................14 
Dynamical systems Mathematical Prediction Models ...............................................15 
CHAPTER THREE: METHODS ..........................................................................................17 
Population ..................................................................................................................18 
Recruitment ................................................................................................................18
 v 
Instrumentation ..........................................................................................................18 
Research Design .........................................................................................................19 
General Procedures ....................................................................................................20 
Cardiopulmonary Exercise Test .................................................................................20 
Oxygen Uptake Data ..................................................................................................20 
Dynamical systems Prediction Model .......................................................................21 
Statistical Analysis and Design ..................................................................................22 
CHAPTER FOUR: RESULTS ..............................................................................................23 
Overview ....................................................................................................................24 
Subjects ......................................................................................................................24 
Hypotheses .................................................................................................................25 
Exploratory Analyses .................................................................................................26 
CHAPTER FIVE: DISCUSSION ..........................................................................................28 
Overview ....................................................................................................................28 
Dynamical systems Prediction Model .......................................................................32 
Non-exercise Estimation Equation ............................................................................33 
Comparison Between Dynamical Systems Model  
and Non-exercise estimation equation .......................................................................34 
 
Exploratory Analyses .................................................................................................35 
Limitations .................................................................................................................38 
Conclusion .................................................................................................................38 
Recommendations for Future Research .....................................................................39 
APPENDIX I: DYNAMICAL SYSTEM TIME SERIES PLOT 1 .......................................41 
APPENDIX II: DYNAMICAL SYSTEM TIME SERIES PLOT 2 ......................................42 
 vi 
APPENDIX II: DYNAMICAL SYSTEMS LINE OF IDENTITY PLOT………………….43 
REFERENCES ......................................................................................................................44 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vii 
LIST OF TABLES 
Table 1 - Anthropometric Characteristics of Patients ............................................................24 
Table 2 - Descriptive Statistics for maximum oxygen uptake obtained during the CPET, 
Dynamical systems model, and non-exercise estimation equations ......................................25 
Table 3 - VO2 Prediction Values Percent Error .....................................................................27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
CHAPTER I 
INTRODUCTION
 
 Acute myeloid leukemia (AML) is a hematological cancer that results in the bone 
marrow producing abnormal red blood cells, white blood cells, or platelets (NCI, 2015). 
AML most commonly occurs in men over the age of 60, with a history of smoking, and a 
previous history of chemotherapy or radiation treatment (ACS, 2016). It is estimated that 
there will be over 60,140 incident cases of leukemia in the United States in 2016, of 
which 19,950 are expected to be AML. In 2014, U.S. cancer surveillance data showed 
that nearly half of the 24,400 reported leukemia mortalities were in patients with AML 
(ACS, 2016).  
 The most common initial phase of treatment for AML patients is inpatient 
induction chemotherapy. The objective of induction chemotherapy is to eliminate all 
cancerous cells from the blood and bone marrow. Patients are generally admitted to the 
hospital to receive intravenous chemotherapy for a week, followed by an extended 
inpatient recovery period lasting for 3-6 weeks (Alibhai, 2012). During this time, patients 
are susceptible to infections and unexpected bleeding and bruising due to low white 
blood cell counts and low platelets, respectively. Patients also experience a myriad of 
other negative side effects from chemotherapy treatment, including hair loss, nausea, 
vomiting, mouth sores, cachexia, general fatigue, and psychological symptoms such as 
depression and anxiety (Bryant et al, 2015; Zimmerman, 2013). 
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To date, there have only been a few studies that have explored the efficacy of 
exercise as a treatment modality to lessen the burden of treatment and mitigate the impact 
of the negative side effects to improve patient outcomes, functionality, and quality of life 
in this cancer population. Four prominent studies of exercise interventions have found 
consistent evidence of improved outcomes in AML patients. The first recorded exercise 
intervention in an AML patient population was an exercise program of five days of 
walking in one  week (Chang, 2008) and found reduced fatigue, anxiety, depression, and 
improved walking distance (2008). In 2009, Battaglini et al. conducted an exercise 
intervention consisting of aerobic and resistance training twice daily, three days a week in 
10 patients with acute leukemia. Aerobic exercise was conducted at 60% heart rate 
reserve (HRR).The authors reported reduced fatigue, depression, and increased 
cardiorespiratory endurance (Battaglini, 2009). Kleplin (2011) and colleagues conducted 
an exercise intervention that included four weeks of walking, stretching, and strength 
training. The authors found that physical function was maintained, while physical quality 
of life was improved. Most recently, in 2012, Alibhai et al. conducted a randomized 
clinical trial that included a progressive training program that was individualized to each 
patient. It consisted of flexibility and resistance training in addition to four to five days a 
week of 30-45 minutes of light to moderate aerobic exercise, defined as 50-75% HRR, or 
a rate of perceived exertion (RPE) of 3 to 6. Alibhai et al. observed reduced fatigue and 
anxiety, as well as improved aerobic fitness and physical functionality (2012). Given the 
existing evidence that exercise interventions are both feasible and beneficial within AML 
populations, proper exercise prescription is necessary to maximize exercise-training 
benefits.  
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According to the American Heart Association, cardiopulmonary functional 
capacity reflects an individual’s ability to perform tasks of daily living as well as quantify 
exercise tolerance and is usually expressed as maximal oxygen uptake (VO2max)  (Arena, 
2007). The gold standard way to assess cardiopulmonary function capacity is through a 
cardiopulmonary exercise testing (CPET) with indirect calorimetry. However, this type of 
testing requires expensive and specialized equipment, and trained personnel. Therefore, 
the assessment of cardiopulmonary function capacity is not always available in many 
different clinical settings, making it very difficult for clinicians, exercise specialists, and 
other health care professionals to benefit from using the results of such test for the initial 
assessment, prescription of exercise, and most recently, as a prognostic tool for post-
treatment complications and mortality in certain cancer populations (Jones et al. 2010, 
Wood et al, 2013).  
An alternative method that can be used for the assessment of VO2max is to perform 
submaximal CPET and use the results of these types of tests to estimate VO2max. These 
types of tests are usually based on heart rate response and its relationship to different 
exercise intensities.  By plotting the heart rate response during the final two stages of a 
submaximal test, and extrapolating the results using linear mathematical equations, one 
can estimate VO2max.  However, this relies on the assumption that HR will respond 
linearly to different increments of exercise intensity. Another assumption is that 
mechanical efficiency is the same for everyone. For these linear equations, data must be 
collected for a minimum of two test stages where HR achieved steady state between 115-
150 beats per minute, significantly reducing the accuracy of the tests, even more so in 
populations where their physiology has been modified through disease or treatments. 
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Grant (1995) found that submaximal CPETs using a cycle ergometer under-
predicted VO2peak by 7.8 mL/kg/min. This estimate is not only outside the accepted 
standard error of measurement of 2 mL/kg/min, but clinically significant when 
considering using the results of such tests for the precise assessment of cardiorespiratory 
function or to use the results of such tests for the prescription of aerobic exercise.  
While it is important to avoid overexertion within clinical populations that are 
sick or recovering from treatments, such as patients with hematological cancer, it is 
critical to conduct training at a level sufficient to elicit the response necessary to induce 
positive adaptations. This presents the need for a method to predict VO2max with the 
precision of a max test, but with the limited effort of submaximal testing, so it can be 
available to clinicians, researchers, exercise physiologists and health care providers using 
aerobic exercise to improve the health and functionality, and use the results of such tests 
to inform better treatment practices.  
Previous prediction models have tried to predict VO2max using skinfolds and body 
mass index (BMI) instead of exercise testing (Jackson, 1990). The standard of error of 
these types of models are usually around 5.3 mL/kg/min with skinfolds and 5.6 
mL/kg/min, with BMI. This was determined to be appropriate for 95% of the adult 
population, but is remains too variable for use in a clinical population. 
 In 2008, Stirling et al. developed a dynamical systems mathematical model to 
predict maximum VO2max. The theory behind this type of model is that the 
cardiorespiratory system is always working to reach equilibrium between demand and 
cardiac output. There is an absolute minimum heart rate for each individual and a 
maximum heart rate that can theoretically be exceeded but is still physiologically limited, 
 5 
and a transient value that changes as a function of demands placed on the system 
(exercise). Mazzoleni, Battaglini, and Mann in 2015 (paper in review) further adapted 
this model to define demand as a function of power (Watts) and cadence pedaling on a 
cycle ergometer. In order to predict VO2max, participants perform a submaximal exercise 
test and the subsequent values are entered into the model. The model calculates 
individual parameters that account for and are dependent on the values from the test. A 
genetic algorithm generates hundred of possible parameters and is run to determine the 
parameters that best fit the model. Through the application of the algorithm, the 
parameters are individualized to the person’s performance during testing, and therefore 
removing the need for any physiological variables such as age, sex, and body mass as 
well as assumptions that all individuals respond the same physiologically to exercise such 
as heart rate and oxygen uptake responses. This initial approach tested in healthy young 
individuals using a cycle ergometer, showed promise, since it would estimate VO2max 
with a level of precision much superior to currently submaximal CPETs and extremely 
accurately when compared to gold standard CPET.  
 Based on the preliminary results of Mazzoleni, Battaglini, and Mann (2015), math 
model prediction using dynamical systems, exploring this testing concept in a clinical 
population such as patients with hematological cancers, where physiological changes due 
to disease and treatment are constantly occurring, may provide insight on the true 
predictability of the model and will help further develop the model and protocols 
designed to be used not only in patients with hematological cancers but many different 
clinical populations. 
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Statement of purpose:   
 The purpose of this study was to determine if a dynamical systems model can 
accurately estimate VO2max using data obtained during a maximal cardiopulmonary 
exercise test (CPET) performed on a cycle ergometer in acute myeloid leukemia patients 
prior to receiving induction chemotherapy treatment. 
 
Research Questions: 
R1: Can a dynamical systems model accurately predict VO2max in acute myeloid leukemia 
patients using all of the data obtained from a CPET prior to beginning chemotherapy 
treatment? 
 
R2: Can a non-exercise prediction equation accurately estimate VO2max in acute myeloid 
leukemia patients using anthropometric data, body fat percentage or BMI? 
 
R3: Can a dynamical systems model more accurately predict VO2maxk in acute myeloid 
leukemia patients data obtained from a CPET performed on a cycle ergometer than a non-
exercise prediction equation? 
 
Research Hypotheses: 
H1: There will be no significant difference in VO2max values between the dynamical 
systems model estimation using all data from a CPET test and the VO2max value attained 
during a CPET performed on a cycle ergometer.  
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H2: There will be no significant difference in difference between the non-exercise 
equation predicted VO2max using anthropometric data (percent body fat or BMI) from 
baseline testing and VO2peak values attained during a CPET performed on a cycle 
ergometer. 
 
H3: There will be no significant difference between VO2max values between the dynamical 
systems model estimation using all data from a CPET test and the VO2max value estimated 
using a non-exercise estimation equation using percent body fat or BMI. 
 
List of Abbreviations and Definition of Terms: 
Acute myeloid leukemia (AML): A type of leukemia that affects the bone marrow and 
causes the production of abnormal red blood cells, white blood cells, or platelets (NCI, 
2005). 
Cardiopulmonary exercise test (CPET): Incremental or graded exercise test using indirect 
calorimetry to determine maximal oxygen consumption (VO2max). 
Maximal oxygen consumption (VO2max): The body’s maximal ability to intake and utilize 
oxygen, and remove waste products during exercise.  
VO2 peak: The highest oxygen uptake (VO2) achieved by a patient during a CPET. For 
this study, the 3 highest values of oxygen uptake during the last stage of the CPET will be 
averaged to derived the maximal oxygen uptake value achieved during the tests and will 
be used for comparison with the math prediction model.  
Dynamical systems model: Model consisting of differential equations for the underlying 
response pattern of oxygen uptake and utilization (Stirling, 2005). 
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Assumptions: 
1. All patients followed pre-assessment guidelines prior to CPET. 
2. All patients gave maximal effort during CPET. 
3. The dynamical systems model determines the best set of individual parameters. 
Limitations: 
1. Relatively small sample size. 
2. Generalizability to other clinical populations as well as general population. 
Delimitations:  
1. Patients over the age of 21. 
2. Recently diagnosed with acute myelogenous or acute lymphocytic leukemia, but 
not yet receiving induction chemotherapy. 
3. Approved by oncologist to participate in CPET. 
4. No pre-existing condition or comorbidity that would increase the risk of 
performing CPET. 
Significance of the study: 
 This model could be instrumental in prescribing more appropriate training 
intensities for exercise interventions in AML patients without having patients to undergo 
a maximal cardiopulmonary exercise test. The dynamical systems model allows for 
individualization of results, without needing to account for individual physiological 
differences because these differences manifest in their transient VO2 responses at various 
power outputs and cadences during a CPET that are capture and incorporated in the 
prediction model. The individualization of the prediction provides more accurate 
estimation of VO2max and MHR exercise, thus potentially improving one’s ability to more 
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accurately prescribe exercise intensity for aerobic training programs. Within AML 
patients, the results of this initial study, may provide clinicians and exercise physiologists 
with a much more practical yet extremely precise way to prescribe aerobic exercise 
intensity to AML patients ensuring that these patients are exercising at a high enough 
threshold to induce adaptations, without over taxing the patient and potentially promoting 
blunted responses. 
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CHAPTER II 
REVIEW OF LITERATURE
Cardiopulmonary Exercise Testing 
 Maximal oxygen consumption (VO2max) is considered the best way to measure the 
capacity of the cardiovascular and pulmonary systems and assess aerobic capacity as well 
as physical fitness (Brooks, Fahey, Baldwin, 2005). The current gold standard method for 
measuring VO2max is a cardiopulmonary exercise test (CPET). In 2003, the American 
Thoracic Society and American College of Chest Physicians released a joint statement on 
the use of cardiopulmonary exercise testing including indications for use, 
implementation, interpretation and clinical application. The purpose of this statement was 
to standardize measurements and provide guidelines for testing, as well as the 
interpretation of results. The American Heart Association also released a statement on 
conducting exercise testing that provides guidelines for certain clinical populations and 
focuses on the diagnostic and prognostic purposes of conducting a CPET (2007). These 
statements attempt to standardize measurements due to the variation amongst exercise 
tests including mode of exercise used protocol.  
Due to the variation among exercise tests, there are certain objective criteria that 
must be met to consider maximal oxygen consumption achieved to be VO2max. These 
criteria propose that the exercise method used must utilize at least 50% of the total 
muscle mass and be continuous and rhythmical (walking, running, cycling) for an 
extended period of time. Additionally, results must be independent of motivation or skill 
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and performed under standard experimental conditions. In order to determine that an 
individual has achieved their maximum capacity, they must meet at least three of the 
following criteria: a high rate of perceived exertion, a respiratory exchange ratio 
exceeding 1.1, a blood lactate level greater than 8 mmoles, a plateau of VO2 even with 
increasing workloads, or a heart rate within 10 beats per minute of the age-predicated 
maximum heart rate (Powers, 2012). If the criteria for reaching VO2max have not been 
met, then the highest attained VO2 is considered the VO2peak. 
Prognostic Value of VO2 
 Kavanagh, Mertens, and Hamm (2002) examined the predictive efficacy of 
exercise capacity measured directly by VO2peak in men participating in cardiac 
rehabilitation following cardiac incidents. This study consisted of the largest sample and 
longest follow-up period to date in a study of men referred for cardiac rehabilitation. The 
authors found that exercise tolerance was the primary predictive factor in all-cause 
mortality, with mortality decreasing substantially by fitness level. The authors concluded 
that improving aerobic power could enhance functional capacity and overall survival. 
Recommendations for further study include exploring the prognostic applications of 
aerobic exercise in women. These findings were supported by Myers et al. (2002) in a 
study examining the prognostic effect of exercise capacity amongst all men, healthy and 
those with previous cardiac conditions to determine if it is an accurate predictor for all 
mortality including healthy populations. They found after accounting for age, METS was 
the single largest predictor of mortality. Each MET was associated with a 12% increase 
in survival. 
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 In 2008, Jones et al. performed a systematic review of cardiorespiratory exercise 
testing in clinical oncology, according to the guidelines set forth in the ATS/ACCP 
statement. Of 852 potential citations, 90 were included in the review. Most of the 
reviewed studies involved operable disease, where testing was performed prior to 
surgery, and the majority of patients were women. In studies involving interventions, 
they were generally conducted during or after treatment. The authors concluded that in 
general, CPET was not optimum for these populations and data reporting standards did 
not comply with national guidelines. Suggestions for further research include 
standardizing guidelines for exercise testing for patients with cancer. 
 In 2010, Jones et al. performed a prospective multisite study to assess the 
potential prognostic benefits of VO2peak in 398 non-small cell lung cancer (NSCLC) 
patients. The authors adjusted their results for age, sex, and all-cause mortality, and found 
that VO2peak was a strong predictor of survival. The underlying physiological mechanisms 
are unclear, but the authors suggest a possible explanation is an inverse relationship 
between cardiovascular performance and cardiovascular disease, as well as muscle 
atrophy and muscular endurance. The results of this study suggest that VO2peak can be a 
predictor of mortality, and improvement in VO2 should be a goal to improve post-
treatment outcomes. In a subsequent study in the same population, Jones examined the 
prognostic value of functional capacity and exercise in NSCLC patients (2012a). Patients 
performed a six-minute walk test and completed a questionnaire about their exercise 
habits. Functional capacity was found to be an independent predictor of all-cause 
mortality. Exercise behaviors were also associated with reduced mortality risk. Findings 
support functional capacity as a prognostic tool, and the authors recommend further 
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research into the efficacy of implementing exercise training to improve functional 
capacity. 
 Jones et al. also assessed VO2peak in four cohorts of breast cancer survivors: before 
treatment, during treatment, after adjuvant therapy for non-metastatic disease, and during 
treatment for metastatic disease (2012b). The authors’ previous conclusions were 
supported by the results seen in this cancer population. They observed that women had 
significantly impaired cardiovascular function across all groups compared to healthy aged 
matched sedentary women. One third of the study population had a VO2max below the 
capacity required for functional independence (15.4 ml/kg/min). They also concluded that 
VO2peak might be a predictor of survivorship in metastatic disease, as patients with a 
VO2peak greater than or equal to 15.4 mL/kg/min had a higher probability of survival 
compared to patients with VO2peak less than 15.4 mL/kg/min 
Current Issues with Cardiopulmonary Testing 
 An issue with performing cardiopulmonary exercise testing in clinical populations 
is the inherent limitations of various body systems due to the diseased state. Palange et al. 
(2007) investigated cardiopulmonary exercise testing as a diagnostic tool for measuring 
functional capacity, assessing shortcoming, tracking disease progression, and for 
prognostic prediction in clinical populations. They discussed how CPETs could be used 
for differential diagnosis to pinpoint specific areas of dysfunction in cardiopulmonary 
fitness, specifically focusing on the system that is the limiting factor. Some of these 
factors include alveolar gas exchange, oxygen delivery, oxygen uptake at the muscle, and 
deconditioning. The authors appraised the diagnostic power of CPET for various diseases 
and dysfunctions and gave recommendations for exercise testing of clinical populations. 
 14 
 In addition to the inherent limitations of maximal testing within specific clinical 
populations, it can also be resource-prohibitive due to the need for specialized equipment, 
trained personnel, and considerable time and space. Submaximal testing can be 
conducted to reduce these constraints, but results in a loss of precision. Thus, there is a 
need for increased precision of maximal predictions derived from submaximal testing. In 
an attempt to address this lack of precision, Montoye et al. developed a multiple linear 
regression model to predict VO2max using output from submaximal testing as predictor 
variables (1986). They utilized a submaximal cycle ergometer test, a graded maximal 
treadmill test, and nonexercise data in their model. The authors determined that perceived 
functional ability (PFA) was the most statistically significant predictor of VO2max. They 
also found that their model was statistically more accurate than the YMCA bike protocol 
for the estimation of VO2max. Montoye et al.’s model accurately predicted VO2max, and 
was more precise when non-exercise variables were included.  
Non-exercise VO2 Prediction Equations 
More recent studies have also utilized multiple regression analysis to predict 
VO2max. Nes et al. developed a non-exercise model for predicting VO2max using data 
from 4,637 male and female participants of the HUNT study, a longitudinal population 
health study in Norway They used data splitting to cross-validate the model using 
different subsets of subjects and found that the model was accurate in predicting VO2peak 
in these healthy populations. The major predictors of VO2peak included age, weight, waist 
circumference, resting HR, and leisure time physical activity. This model could be 
important for predicting VO2peak in a non-clinical setting when exercise testing is not 
feasible (Nes, Janszky, Vatten 2011). 
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In a subsequent study using data from the HUNT study, Nes et al. (2014) used 
previously established model to predict all-cause mortality among cardiovascular disease 
patients. They found that cardiorespiratory fitness was inversely related to mortality 
amongst men and women at baseline, after adjusting for potential confounders. These 
findings support the predictive nature of the model and its application for healthy or at-
risk populations. 
Dynamical systems Mathematical Prediction Models 
In 2008, Stirling developed a non-exercise mathematical based prediction model. 
Stirling’s is a dynamical model of heart rate kinetics for predicting heart rate response to 
exercise. The model gives physiological information about the subject based on oxygen 
uptake and heart rate response as a function of time and intensity at all exercise 
intensities based on physiological principals. One potential limitation of this study is that 
it does not account for individual variability in heart rate response to exercise by only 
examining constant intensities. 
Mazzoleni, Battaglini, and Mann (paper in review) developed a nonlinear model 
to predict heart rate dynamics across a varying range of exercise intensities, in order to 
account for an individual’s transient heart rate responses. The authors’ model builds on 
Stirling’s original model using cycling but includes a drive function of power (Watts) and 
cadence. The model includes parameters that are related to the individual’s physiology, 
allowing the model to be individualized to each patient. Their model was capable of 
predicting heart rate at various transient exercise intensities accurately and showed that it 
was able to account for individual differences in physiology when making predictions. 
They also confirmed that heart rate can be more accurately predicted by power output and 
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cadence than power output alone, what previous models used. A separate dynamical 
systems model is able to use the same functions and parameters and can be applied to 
VO2 in order to predict maximal oxygen uptake. 
 17 
CHAPTER III 
METHODOLOGY
 
Population 
 The study population included seventeen patients recently diagnosed with acute 
myelogenous or acute lymphocytic leukemia, who had participated in the Exercise and Quality 
of Life in Leukemia/Lymphoma Patients (EQUAL) phase II study. Patients included men and 
women between 28 and 69 years old. Eligible patients were admitted for induction chemotherapy 
treatment within 3 days of beginning treatment. Patients were informed of the EQUAL phase II 
study by their oncologists and approved to participate before being contacted by a research team 
member. Upon receiving further information regarding the study and agreeing to participate, 
patients signed an informed consent approved by the Lineberger Comprehensive Cancer Center 
Protocol Review Committee (LCCC 1234) and the University of North Carolina Institutional 
Review Board (IRB). 
 The inclusionary criteria for the EQUAL phase II study included: (1) at least 21 years 
old,  (2) recently diagnosed with acute leukemia, (3) approved by an oncologist to participate in 
cardiopulmonary exercise testing (CPET), and (4) able to read and understand English. 
Exclusionary criteria included any pre-existing conditions that would increase the risk involved 
of performing CPET such as: cardiovascular disease, respiratory disease, musculoskeletal 
disorders and disease, and/or altered mental or psychological state that could affect 
understanding the informed consent. Exclusion from being eligible to participate in the study was 
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determined by reviewing the patient’s medical history questionnaire and consulting with the 
patient’s oncologist.  
The medical history questionnaire completed by patients prior to participation included a 
general medical history, as well as a detailed cancer history including previous and planned 
treatment. Prior to participating in the CPET, patients underwent a complete physical 
examination including a resting ECG and a Multigated Acquisition Scan (MUGA) to assess 
cardiovascular function. 
Instrumentation 
 Maximum oxygen uptake (VO2max) and for those patients who weren’t able to achieve 
VO2max (VO2peak) and MHR achieved during the CPET will be used in this study from the initial 
cardiopulmonary test administered to these patients enrolled in the EQUAL phase II trial. CPET 
tests were performed using a cycle ergometer (Monark 874E, Goteborg, Sweden). Heart rate was 
measured using a Polar heart rate monitor (Polar Electro Inc., Lake Success, NY) and was 
recorded every 10 seconds. Blood pressure was assessed by auscultation using a 
sphygmomanometer (American Diagnostics Corporation, Hauppage, NY) and a Littman 
stethoscope (3M, St. Paul, MN). Oxygen uptake was measured via a portable metabolic gas 
analysis system (Cosmed Portable K4b2, Rome, Italy). At the end of each stage and at the end of 
the test, the patient used the Borg Rate of Perceived Exertion (RPE) scale (6-20) to determine 
rate of perceived exertion. Data from the CPET will be used for estimations of VO2max and MHR 
using dynamical systems modeling thought differential equations and will be processed and 
analyzed using MatLab R2014a (MathWorks, Boston, MA) on a computer (Valkyrie 17334, 
IBuyPower, Industry, CA). 
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Research Design 
This study used data from the EQUAL phase II trial (IRB # 13-1082), a pilot randomized 
clinical trial designed to test the effects of exercise on the alleviation of multiple treatment 
related side-effects commonly developed in acute leukemia patients undergoing cancer 
treatments, including fatigue, loss of body mass with significant loss of muscle mass, depression, 
anxiety; which are common side-effects observed in this cancer population during induction 
phase of treatment along with other side-effects that occurs in a more patient specific basis . 
These side effects are known to significantly reduce the quality of life of this cancer population. 
All patients enrolled in the EQUAL phase II trial, underwent a CPET test prior to beginning 
chemotherapy treatment. The heart rate (HR) and oxygen uptake data obtained during the CPET 
were used to devise an estimation of maximum VO2 using mathematical modeling (dynamical 
systems) and  compared to the maximum values obtained from the CPET for oxygen uptake.  
General Procedures 
 Upon being determined eligible for the study and cleared by an oncologist to participate, 
the EQUAL phase II study, the study procedures were explained in full to all patients, and if 
interested in participating in the study, patients were asked to sign an informed consent form. 
The study protocol included a number of baseline physical, functional, and psychosocial 
assessments, however, only data obtained from CPET (Oxygen uptake and HRs collected during 
the test) will be used for the current study. Patients enrolled in the EQUAL phase II study were 
randomized into a standard treatment control group, and an intervention group. However, 
because baseline assessments were completed prior to receiving treatment, this study used CPET 
data from all patients regardless of group assignment.  
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Cardiopulmonary Exercise Test (CPET) 
 Before beginning the CPET, patients were fitted with a facemask to collect respiratory 
exchange gases. Patients were also familiarized with the cycle protocol and the stationary cycle 
ergometer; and the seat was adjusted at approximately 120° of extension between the thigh and 
the lower leg. The protocol used was previously shown to be appropriate for determining 
cardiopulmonary capacity in cancer patients (Jones et al, 2009). Prior to beginning the test, 
resting VO2 measurements were taken for two minutes while the participant was seated on the 
bike. This was followed by a two minute warm up, a period where patients pedaled at a cadence 
of 50 revolutions per minute (RPM) with a resistance of zero Watts (W). The cadence of 50 rpm 
was held constant for the duration of the CPET. Following the warm up, the initial workload was 
set at 25 Watts. The workload increased every minute by 5 to 20 W depending on the patient 
response during the warm up phase of the test, until volitional fatigue was reached at the end of 
the test. The criteria for test termination included: volitional fatigue, respiratory exchange ratio 
(RER) exceeding 1.10, or limitation by physical symptoms. The test was immediately terminated 
if the patient experienced chest pain, dizziness, nausea, if there were ischemic changes on the 
ECG, BP response was abnormal, or arterial oxygen saturation was 85% or less. Throughout the 
test, HR, BP and VO2 were measured, with RPE taken at the end of every stage and at the end of 
the test. Maximum oxygen uptake was determined by averaging the three highest values of 
oxygen uptake during the last minute of the test. Patients completed a cool down period of 10 W 
resistance at their own pace until their HR dropped below 120 bpm. 
Oxygen Uptake Data 
 The oxygen uptake collected every 4-breaths throughout the entire CPET will be used for 
the prediction of maximum oxygen uptake using system dynamics. Furthermore, oxygen uptake 
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responses from the first two stages of the test will also be used for the prediction of maximum 
oxygen uptake using system dynamics and will be compared to the maximal oxygen uptake 
achieved by subjects during the CPET.  
Dynamical systems Prediction Model 
 The mathematical model used for this study builds upon the work of Stirling and 
Zakynthinaki (2008), who used dynamical systems theory and physiological insight to construct 
a model for predicting oxygen uptake and heart rate responses of individuals based on system 
equilibrium. Their model is able to account for the nonlinear nature of oxygen uptake response 
across a range of constant exercise intensities, but does lacks the ability to predict across 
transient exercise intensities. The current model by Mazzoleni, Battaglini, and Mann (2015), 
expands on their model by developing a state equation for oxygen uptake demand and the 
addition of a multi-variable exercise intensity function. This model demonstrates that oxygen 
uptake is more accurately predicted by a combination of power output and cadence. Due to the 
nonlinear nature of this problem, a heuristic algorithm was developed for the parameter 
estimation. The parameter estimation algorithm was verified using synthetic data and then 
applied to oxygen data collected from laboratory cycling test performed on several healthy, 
regularly exercising adults. The resulting model predictions of the oxygen uptake responses 
showed good agreement with the experimental data (R2 = 0.92 ± 0.04). Additionally, the 
experimental results verified that exercise intensity during cycling is a nonlinear function of both 
power output and cadence. This mathematical model can also be used to determine the maximal 
oxygen uptake of an individual by utilizing the heuristic parameter estimation algorithm that was 
developed for making model predictions. The equilibrium-based model construction allows for 
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the algorithm to estimate maximal oxygen uptake with a high degree of accuracy when transient 
effects in the oxygen uptake response are observed. 
Statistical Analysis 
All statistical analysis were performed using SPSS software (IBM, Durham, NC) and an 
alpha level was set a priori at p < .05. 
Descriptive statistics, means and standard deviations, were calculated for maximum 
oxygen uptake achieved during the CPET and for the mathematically predicted value derived 
from system dynamics and the non-exercise prediction equation using BMI and body fat 
percentage. Maximum oxygen uptake attained from the CPET was compared to the predicted 
values from the dynamical systems model and the non-exercise prediction model using 
dependent samples t-test.  
Power calculations may not directly apply to this study, since the mathematical models 
can achieve a high level of precision with only one subject. However, to prove that the model 
can also be used to predict maximal oxygen uptake with a high level of precision, such as in a 
cohort of patients where physiological alterations due to disease and treatment are expected to be 
extremely heterogeneous, data from 14 subjects was used in this study, for all comparisons 
between actual data collected from the CPETs and the predicted maximal oxygen uptake and 
MHR derived from dynamical systems model.  
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CHAPTER IV 
RESULTS 
 
Overview 
The purpose of this study was to determine if a dynamical systems model can accurately 
estimate VO2max from data obtained during a maximal cardiopulmonary exercise test (CPET) 
performed on a cycle ergometer in acute myeloid leukemia patients prior to receiving induction 
chemotherapy treatment. Due to patients not truly reaching their maximum oxygen uptake during 
the CPET test based on recommended criteria for attainment of maximum oxygen uptake 
describe in the methods section, the term VO2peak was used to denote the maximum oxygen 
uptake attained by the patients during the CPET. The secondary purpose was to compare VO2peak 
attained during a maximal cardiopulmonary exercise test to a non-exercise VO2max estimation 
equation that includes BMI or body fat percentage. The tertiary purpose was to evaluate if there 
was a significant difference between the dynamical systems model predicted VO2max and the 
VO2max estimated from the non-exercise equation using percent body fat and BMI. Exploratory 
analyses were also conducted to capture the inter-variability between subjects that were not 
captured with absolute values between the non-exercise estimations, the dynamical systems 
model and the experimental values obtained. All data were analyzed using the statistical software 
SPSS, version 23 for Mac. Alpha level was set a priori at 0.05 for all main analyses. Descriptive 
statistics are presented in the form of means and standard deviations.  
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Subjects 
 Seventeen subjects were recruited from the EQUAL phase II clinical trial at UNC 
Lineberger Comprehensive Cancer Center and completed the baseline assessment including a 
CPET to assess cardiopulmonary function. All seventeen patients were included in the data 
analysis. One patient was missing body fat percentage calculation; therefore, a mean substitution 
was imputed for this missing value and used for the calculation of the estimated VO2max using the 
non-exercise equation. Patient characteristics are presented in Table 1. 
 
Table 1: Anthropometric Characteristics of Patients, N=17  (mean ± SD) 
Characteristics Baseline 
Age (years) 53 ± 15.3 
Height (cm) 171.8 ± 14.9 
Weight (kg) 86.1 ± 20.2 
BMI 29.3 ± 6.6 
Body Fat % 30.2 ± 7.0 
 
Paired samples t-tests were used to compare the dynamical systems model estimated VO2max and 
non-exercise estimated VO2max to maximum oxygen uptake obtained during the CPET. 
Descriptive statistics for VO2 values are presented in Table 2. 
 
 
 
 25 
Table 2: Descriptive Statistics for maximum oxygen uptake obtained during the CPET, 
Dynamical systems model, and non-exercise estimation equations (mean ± SD) 
 mL/kg/min L/min 
VO2peak obtained during CPET 18.09 ± 4.89 1.54 ± 0.57 
Dynamical systems model estimated VO2max 22.45 ± 7.00* 1.92 ± 0.78* 
Non-exercise estimation VO2max including BMI 19.91 ± 7.78 1.66 ± 0.59 
Non-exercise estimation VO2max including percent body fat 21.49 ± 5.92* 1.85 ± 0.63* 
*<.05=significant different from VO2peak obtained during the CPET. 
Hypotheses 
 Hypothesis 1, there will be no significant difference between the dynamical systems 
model VO2max estimation using all data from a CPET test and the VOpeak value attained during a 
CPET performed on a cycle ergometer. A significant difference (p < .001) was found between 
VO2peak attained during the CPET and dynamical systems model predicted VO2max. 
Hypothesis 2, that there will be no significant difference between the non-exercise 
equation predicted VO2max using anthropometric data (percent body fat or BMI) from baseline 
testing and VO2peak values attained during a CPET performed on a cycle ergometer. A significant 
difference (p < .005) was found between VO2peak attained during a CPET performed on a cycle 
ergometer  and the non-exercise equation using percent body fat predicted VO2max . There was no 
significant difference between VO2peak attained during a CPET performed on a cycle ergometer 
and the non-exercise equation using BMI predicted VO2max .  
Hypothesis 3, that there will be no significant difference between VO2max values between 
the dynamical systems model estimation using all data from a CPET test and the VO2max value 
estimated using a non-exercise estimation equation using percent body fat or BMI.  There was no 
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significant difference between dynamical systems model predicted VO2max and estimated VO2max 
using percent body fat or BMI. 
Exploratory Analysis 
 Exploratory analyses were conducted to capture the inter-variability between subjects that 
was not captured when analyzing the data using absolute values. The VO2max values attained 
from the dynamical systems model and the non-exercise estimation equations were compared to 
the maximum oxygen uptake attained during the CPET data for each subject and expressed as 
percent difference from the “gold standard” CPET attained value. These values are listed in 
Table 3 as ml/kg/min ± percent change from the VO2peak. 
 The dynamical systems model overestimated maximum oxygen uptake by 25.28% (± 
27.20) while the non-exercise equation including percent body fat overestimated maximum 
oxygen uptake by 15.20% (±39.33), and by 26.21% (±40.75) when including BMI and body fat 
percentage respectively, when compared to the gold standard maximum oxygen uptake (VO2peak) 
attained during the CPET. Correlational analyses were used to analyze the relationship between 
the model predicted and experimental VO2 values over the duration of the CPET. The correlation 
was statistically significant, R2=0.92.  
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Table 3. VO2 Prediction Values as Percent Error 
 
 
 
 
 
Subject CPET 
VO2peak 
Model Predicted 
VO2max ± % Δ 
Equation Estimated 
VO2max  BMI ± % Δ 
Equation Estimated 
VO2max  Body Fat ± % Δ 
1 19.25 19.68 (+2.23%) 21.46 (+11.51%) 26.78 (+39.10%) 
2 18.41 24.92 (+35.37%) 25.95 (+40.93%) 28.08 (+52.50%) 
3 22.60 23.11 (+2.26%) 8.00 (-64.61%) 13.08 (-42.11%) 
4 25.11 32.36 (+28.89%) 11.91 (-52.59% 19.66 (-21.69%) 
5 16.33 16.40 (+0.42%) 13.59 (-16.84%) 23.84 (+45.95%) 
6 22.83 25.08 (+9.86%) 29.25 (+28.14%) 32.91 (+44.18%) 
7 11.62 20.62 (+77.55%) 12.97 (+11.64 %) 17.25 (+48.50%) 
8 15.39 18.21 (+18.30%) 21.01 (+36.50%) 20.78 (+35.04%) 
9 22.49 35.62 (+58.39%) 15.53 (-30.95%) 14.70 (-34.63%) 
10 14.43 14.49 (+0.42%) 14.38 (-0.37%) 13.01 (-9.87%) 
11 21.29 22.67 (+6.51%) 21.93 (+3.00%) 22.65 (+6.37%) 
12 12.95 22.76 (+75.72%) 21.00 (+62.13%) 21.48 (+65.79%) 
13 18.01 29.33 (+62.83%) 23.07 (+28.11%) 18.50 (+2.73%) 
14 24.18 30.90 (+27.75%) 39.59 (+63.72%) 29.15 (+20.54%) 
15 6.68 7.45 (+11.59%) 11.68 (+74.90%) 14.95 (123.79%) 
16 17.40 17.50 (+0.61%) 24.18 (+38.97%) 21.49 (+23.52%) 
17 18.50 20.56 (+11.13%) 22.97 (+24.18%) 27.0 (+45.93%) 
 28 
CHAPTER V 
DISCUSSION
 
Acute myeloid leukemia is a hematological cancer that results in the formation of 
abnormal red and white blood cells and platelets from the bone marrow and occurs in over 
54,000 new patients each year (ACS, 2014). The initial stage of treatment includes inpatient 
induction chemotherapy for a week, followed by several weeks of inpatient recovery. During this 
time, patients are extremely susceptible to infections, bleeding, and bruising in addition to 
numerous of other negative physical and psychological symptoms associated with their 
chemotherapy treatment and reduced physical activity, including cachexia, fatigue, anxiety, 
depression, and sleep disturbances within many others.  
 Currently, there have been four studies that have examined the efficacy of exercise 
interventions in this population with the goal of mitigating the symptom burden, improving 
patient outcomes such as functionality and quality of life. All four studies found that exercise 
with this population is not only safe but also feasible and efficacious in alleviating the common 
physical and psychological decline experience by the majority of patients. The first ever program 
in this population reported reduced fatigue, anxiety, depression and improved walking distance 
in response to walking five days per week (Chang, 2008). An exercise intervention consisting of 
aerobic and resistance training twice daily, three days a week reported reduced fatigue, 
depression, and increased aerobic fitness (Battaglini, 2009). An intervention consisting of four 
weeks of walking, stretching, and strength training reported maintenance of physical function 
and improved quality of life (Keplin, 2011). Most recently, a randomized clinical trial consisting 
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of a progressive training program individualized to each patient comprising of flexibility, 
aerobic, and resistance training four to five days a week, observed reduced fatigue and anxiety, 
as well as improved aerobic fitness and physical functionality (Alibhai, 2012). 
 While all studies to date have demonstrated the desired positive outcomes, the exercise 
interventions varied drastically from study to study in terms of exercise prescription and exercise 
modality. Due this heterogeneous body of literature examining the effects of exercise in 
leukemia patients, if is not possible at this time to make precise recommendations regarding the 
best and most efficacious prescription of exercise to maximize the benefits of exercise to this 
cancer population. Exercise interventions must be prescribed in a way that will maximize the 
physiological and psychological benefits without overtaxing the body and placing an undue 
burden on the patient. In order to properly prescribe an exercise program for an individual 
patient, there must be a standardized and objective method for assessing a patient’s current 
physical fitness and prescribing exercise in relation to this measurement.  
 An individual’s cardiopulmonary functional capacity expressed as maximum oxygen 
uptake (VO2max) is an individual’s ability to uptake and utilize oxygen during exercise and 
reflects an individual’s ability to perform tasks of daily living as well as tolerate exercise (Arena, 
2007). Cardiopulmonary functional capacity is considered among exercise physiologists as the 
single best measurement of overall fitness of an individual. Once an individual’s VO2max is 
known, exercise can be prescribed as a percentage of this number, typically in terms of a 
corresponding heart rate due to the nature of the relationship between heart rate and VO2. Some  
studies have shown that VO2 is an independent predictor of mortality in different cancer 
populations (Jones et al. 2010, Wood et al., 2013). 
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The gold standard method of measuring VO2 is through a cardiopulmonary exercise test 
(CPET) using indirect calorimetry. However, these tests require expensive and specialized 
equipment and personnel and may not be feasible or practical in all settings. An alternative to 
this, is to perform a submaximal exercise test and use the results to estimate VO2max. This method 
utilizes the relationship between heart rate and various exercise intensities, however, it is 
dependent on the assumption that an individual’s heart rate will respond linearly to incremental 
exercise, and that mechanical efficiency is similar among different individuals. These 
submaximal predictions require an individual to achieve steady state in two stages during the 
exercise test, and due to the assumptions mentioned above, significant error of estimation is 
known to occur in different populations. In cancer patients such as those being treated for 
leukemia, the accuracy of submaximal tests are may be even more pronounced. In leukemia 
patients, due to the negative effects of the disease and treatment on the patient’s physiology,  the 
patients’ exercise response most likely will violate submaximal testing assumption of estimation, 
leading to even more error of estimation. Non-exercise VO2 prediction models have also been 
developed using skinfolds and BMI, with a standard error of 5.3 and 5.6 mL/kg/min respectively 
when compared to the gold standard CPET (Jackson, 1990). While this method would be 
acceptable for certain healthy adult populations, its use in clinical populations such as cancer has 
been very little evaluated if evaluated at all. 
Submaximal and non-exercise prescription models appear not to be the best alternative 
methods to estimate VO2max in cancer patients due to assumptions that assume linear relationship 
between HR and VO2, similar mechanical efficiency between patients, and altered physiology of 
patients due to their disease and treatments. However, to our knowledge, no study has evaluated 
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to date the precision of these methods to be used as alternative to gold standard CPET in 
Leukemia patients.  
Stirling (2005, 2008) developed a dynamical systems model of the heart rate and oxygen 
uptake responses to exercise. However, this model was limited in its application because it was 
only able to predict hear rate and oxygen uptake responses at constant exercise intensities. 
Mazzoleni and colleagues (2016) expanded upon this model and incorporated a demand function 
to capture the dynamics of the system at non-steady state and transient exercise intensities. They 
were also able to utilize this model to make predictions for the maximum heart rate and maximal 
oxygen uptake values of an individual. For the case of cycling, an individual performs a 
cardiopulmonary exercise test on a cycle ergometer in the lab and the subsequent values for heart 
rate, oxygen uptake, power, and cadence are entered into the model as time series variables, and 
the dynamical systems model then uses a heuristic algorithm to determine individual parameters 
that best fit the model and predict maximum heart rate and maximal oxygen uptake. The 
individual parameters are based on an individual’s physiology and performance during the test 
and allow the model to be customized to their performance, removing the need for physiological 
variables such as age, sex, and body mass, as well as assumptions that all individuals respond the 
same physiologically to exercise. Based on the preliminary results of this model prediction using 
dynamical systems, exploring this concept in clinical populations where physiological changes 
are constantly occurring may provide insight into the prediction capabilities so that in the future, 
using very little data, such models could predict VO2max with a very high agreement to gold 
standard CPET without the need for expensive equipment and specialized personnel to run such 
tests. 
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The primary purpose of this study was to determine if a dynamical systems model can accurately 
estimate maximum oxygen uptake from data obtained during a maximal CPET performed on a 
cycle ergometer in acute myeloid leukemia patients. The secondary purpose was to compare 
maximum oxygen uptake attained during the CPET, to a non-exercise estimation equation using 
BMI and body fat percentage. The tertiary purpose was to evaluate if the dynamical system 
model predicted maximum oxygen uptake was significantly different to the non-exercise 
estimation equation using BMI or body fat percentage. 
Dynamical Systems Model 
 When compared to the maximum oxygen uptake attained by the patients during the 
CPET during baseline testing, the dynamical systems model estimation was significantly higher. 
The maximum oxygen uptake obtained by these patients was categorized as a VO2peak due to 
their inability to meet the standard criteria for VO2max. These include: a high rate of perceived 
exertion (>17), a respiratory exchange ratio exceeding 1.1, a blood lactate level greater than 8 
mmoles, a plateau of VO2 even with increasing workloads, or a heart rate within 10 beats per 
minute of the age-predicated maximum heart rate (Powers, 2012). For rate of perceived exertion, 
seven patients reported an RPE >17. This is a subjective measurement, and relies on the patient 
understanding the scale, and also being able to tolerate a maximal level of exertion. These 
patients were recently diagnosed with leukemia and admitted to the hospital for inpatient 
treatment, and were all of low physical fitness, therefore, unlikely to be able to tolerate high 
levels of physical exertion without extreme fatigue. Of the seventeen patients, ten cited leg 
fatigue as their reason for terminating the test. Only one patient had a plateau of VO2 with 
increasing workloads. Three patients had a heart rate within 10 bpm of age-predicted maximum 
heart rate. Due to the failure to meet these criteria, the highest three values for oxygen uptake 
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during the final minute of the test were averaged to determine VO2peak. Therefore, the VO2 value 
achieved by most patients in this study is not believed to be their true physiological max that 
they could achieve, thus the dynamical system model over-predicting VO2max. The dynamical 
systems model represents VO2 as the change in oxygen uptake kinematics in response to the 
demands placed on the system that disturb the equilibria of the heart rate and VO2. The system 
has minimum and maximum values, as well as the sub-maximal demand that is a function of 
exercise intensity. The model is able to recognize that those sub-maximal values experimentally 
obtained are not the maximal values of the system in the case that a test is terminated early, thus 
the model over-predicting in some cases (Stirling 2005, Mazzeloni 2016). 
Non-Exercise Estimation Equations 
 The most commonly accepted and widely used equations for predicting VO2max were 
validated using young, healthy populations and developed for use during steady state exercise. In 
2003, Peterson and colleagues examined the efficacy of two of the most commonly used 
equations, ACSM and Foster, for older, deconditioned adults. They found that the ACSM 
equation had an overestimation bias for both men and women with the highest overestimation in 
more fit women. The Foster equation was determined to be appropriate in this population with an 
R2=0.7 (Peterson, 2003.) A validity study of non-exercise equations using adult females found 
that an equation using only one measure of physical activity was just as valid as those with more 
physical activity questions, but should be used in conjecture with a multivariate regression model 
using age, gender, and anthropometric data (Cardinal, 1996). In 2005, Jurca et al. performed an 
analysis of three studies assessing cardiorespiratory fitness using large samples of adult men and 
women. The National Aeronautics and Space Administration/Johnson Space Center utilized the 
gold standard maximal exercise test (n=1863), Aerobics Center Longitudinal Study (n=46,190) 
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utilized a modified maximal test, and the Allied Dunbar National Fitness Survey (n=1706), 
utilized a submaximal test, the non-exercise equations applied to the three populations included 
age, gender, resting heart rate, and physical activity measurement. The NASA model was most 
accurate, due to the use of the gold standard VO2max exercise test, but all the estimations were 
valid in all three populations; NASA r=0.81, ACLS r2=0.77, and ADNF r2=0.76. (Jurca, 2005). 
The current study uses a non-exercise equations use age, gender, physical activity, and 
anthropometric data to predict VO2 developed by Jackson and Blair (1990). When compared to 
the VO2peak attained by patients during the CPET, there was no significant difference (p<.05) 
when using BMI as a variable in the equation. However, when using body fat percentage as a 
variable it was significantly higher. As a general trend, both equations overestimated VO2 with 
the exception of a few patients, with the body fat estimation being the highest. Body mass index 
is a ratio of height to weight, whereas, body fat percentage is a measure of body composition 
between fat and fat free mass and therefore correlated to physical fitness. Most of these patients 
experience a loss of body mass as a result of their disease, and changes in body fat percentage 
may not accurately represent the normal physiology parameter used to develop such equations. 
The BMI equation may be more appropriate in this population because it is more standardized to 
exclude individual physiology.  These equations have not previously been validated in this 
population, but may be a viable alternative if other methods for assessing VO2 are not available. 
If utilized, BMI should be used as a predictor. 
Comparison Between Dynamical Systems Model and Non-exercise Equations 
 There was no significant difference between VO2max predicted by the dynamical systems 
model and the non-exercise estimation equations using body fat percentage and BMI. This could 
be attributed to the overall over-estimation bias of VO2 for the reasons mentioned previously. 
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This could also be attributed to the individual variability that was not captured by the paired 
samples t-tests and will be discussed further in exploratory analysis. The dynamical systems 
model consistently over-predicted, to what would be assumed to be the true physiological 
VO2max, whereas the estimation equations over- and under- predicted with large fluctuations 
between individuals. In this population, non-exercise or mathematical predictions may be better 
indicators of cardiorespiratory fitness due to their inability to perform maximal cardiorespiratory 
tests. In the current study, it appears that the dynamical systems model overestimates, it may be 
more accurate that the CPET obtained value misrepresents their true maximal VO2 value. The 
underlying assumption is that the obtained value is their physiological max is violated in this 
population due to their disease processes and poor physical fitness. The non-exercise equations 
are more accurate in this population because they account for low physical activity level, age, 
and body mass index. These patients have very low physical activity levels, are older adults, and 
have a BMI of (29.3 ± 6.6). 
Exploratory Analysis 
 Due to the individualized nature of the dynamical systems model, exploratory analyses 
were conducted to capture the inter-variability that was not reflected in the statistical tests ran. 
The variance between patients and within the sample was not equal, therefore means do not 
capture the individual differences for each prediction method. For example the dynamical 
systems model was very accurate with a few patients, and off by as much as 25%. The dynamical 
systems model had an error of 25.28% (± 27.20), however, the correlation between the model 
predicted VO2 values and those obtained during the CPET was, r(16) = 0.96 p <.05 indicating 
that the model may produce a more accurate evaluation of VO2max in this cancer population 
where the CPET performed on the cycle ergometer and due to the disease and treatments may 
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pose a tremendous burden on the patients ability to perform at their best allowing for 
achievement of maximum oxygen uptake . Examples of time series plots are listed below, in the 
appendices I and II. 
Table 3 presents the percent change between VO2peak attained and predicted VO2max using 
the dynamical systems model and non-exercise equations including either BMI or percentage 
body fat. This demonstrates the potential predictive capability of the model in scenarios where a 
patient’s physical limitations to the test are believed to hinder the attainment of a true 
representation of their cardiorespiratory capacity. Factors such as reduced muscular endurance 
and strength, lower hemoglobin levels, disease related physical impairments, psychological 
stress, lack of motivation or energy due to cancer-related fatigue, and unfamiliarity with exercise 
testing on a cycle ergometer can all contribute to the attainment of lower VO2max during a CPET. 
The non-exercise estimation equations are designed to assist in the estimation of the patient’s 
cardiopulmonary capacity in scenarios where patients are either unable to perform a CPET, had a 
percent error of 15.20% ± 39.33 when including BMI, and 26.21% ± 40.75 when including body 
fat percentage. Table 3 shows how these prediction equations are inconsistent in the direction of 
error between individuals, while both tending to significantly overestimate with large standard 
deviations. The reason for these discrepancies between individuals may be due to the tremendous 
heterogeneity between individuals including different age groups, size, and varied body 
compositions.   
Appendix III contains a line of identity plot of the model predicted VO2max values and the 
VO2peak values obtained during the CPET. The dynamical systems model predicted VO2 was 
within 10% error for seven of the patients (four female, three male). Of those patients, three were 
the closest to obtaining a VO2max per the criteria with a maximum heart rate within ten beats per 
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minute of their age predicted maximum, and a rate of perceived exertion greater than 17, with 
one patient reaching a plateau in VO2 with increasing workloads. Four of the patients within this 
subgroup cited leg fatigue as their reason for terminating the test. The comorbidities of this group 
include four patients with arthritis, two with anxiety and depression, one with diabetes, one with 
COPD. The average age of this subset was 50, BMI of 30.6, and body fat percentage was 29.5. 
The average test duration was 6.63 minutes with a range of 5-11.36 minutes 
A second subset of the patients with the highest percent error between dynamical systems 
model predicted VO2max and CPET obtained VO2peak consisted of four patients with error of 
+58%-77%. There were two men and women with the average age of 56, BMI of 29.7, and body 
fat percentage of 34.9. None of these patients achieved a maximum heart rate within 10 beats per 
minute of their age predicted max, two had a final RPE of 18, all cited leg fatigue as their reason 
for terminating the test. The average duration of the test was 5.145 minutes with a range of 2.23-
7.5 minutes. The outlier of this subset and the entire population was a 28-year-old male with a 
BMI of 43.4 and a body fat percentage of 45.6. This patient and one other in this subset had 
arthritis, two had hypertension. 
The patients that the model was most accurate for tended to be women, younger than the 
average age of the population, with lower body fat percentage and BMI, although the entire 
population was overweight or obese with the exception of one. The duration of test was 
associated with more accurate final predictions. Comorbidities did not have an effect on the 
predictive ability. A longer test would not only provide more data points for the model but would 
be associated with higher workloads, resulting in higher heart rates and RPE values and higher 
VO2peak values. 
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Limitations 
 Potential limitations for the current study include sample size and generalizability of 
study results. The exclusion criteria for the EQUAL phase II trial, limited the recruitment of 
patients who did not have any contra-indication to participate in maximal exercise testing or 
regular exercise of moderate intensity. Therefore, only patients without any physical limitations 
besides the potentially altered physiology due to leukemia and treatments participated in the 
study. However, these results are an important first step in testing the capabilities of the 
dynamical systems model and further research is needed to continue to explore the accuracy 
capacity and usability of such model in the oncology setting. Another limitation of the current 
study is the use of retrospective data, where control over the protocol and variation in the testing 
parameters could not be manipulated to increase the ability of the dynamical systems model to 
produce different levels of estimation. For example, if cadence could be altered during testing 
promoting more pronounced alterations on the physiological response of the patients HR and 
oxygen uptake during testing, the dynamical systems model could potentially increase its 
estimation accuracy. 
Conclusion 
 Exercise interventions with adults undergoing inpatient chemotherapy treatment are 
novel in nature and vary in their implementation. Since exercise has been shown to be safe and 
feasible to be administered to leukemia patients undergoing treatment, it is important to ensure 
that exercise intensities are appropriate to alleviate decline or even promote improvements in 
cardiorespiratory capacity. From a prognostic standpoint, a higher VO2 value has been associated 
with better post-transplant outcomes, which could be similar in leukemia patients undergoing 
treatment. Being able to use parameters such as HR and oxygen uptake to improve the exercise 
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prescription may prove to be an important factor in providing prescriptions that can be more 
efficacious in promoting most benefits. Based on the results of this preliminary study, the use of 
a dynamical systems model and/or a non-exercise estimation equation that uses BMI may 
provide a better overall assessment of the cardiopulmonary capacity of leukemia patients, that is 
not limited to the physical inability or test specifics that can produce erroneous evaluation of the 
current cardiorespiratory capacity to be used in the context of an exercise prescription. However, 
further research must be conducted so better methods for the assessment of cardiorespiratory 
function can be developed to account for specific physiological alterations in clinical population, 
that can be captured by the test for a better and more precise assessment be achieved.   In 
conclusion, since transient changes captured in VO2 in response to the demands placed on the 
equilibria of the dynamical system, the system is not subject to the same physiological 
limitations of CPET, potentially providing a more precise VO2max determination.  However, this 
is just speculation at this time since this is just the first study to attempt to investigate the 
dynamical systems model VO2max predictability in leukemia patients and more research is needed 
to confirm or refute this possibility. 
Recommendations for Future Research 
 As the first study of it’s kind, there are many applications for future research. Exercise 
prescriptions based on heart rate are difficult in this population due to the variability in their day-
to-day heart rate response. More frequent measurements of HR during a submaximal effort 
would allow for dynamical systems modeling to capture individual differences and fluctuations 
due to transient responses providing better understanding of HR responses during exercise which 
could translate in better exercise prescription using HR. The dynamical systems model has been 
shown in previous studies that it can produce accurate estimations of HR responses with limited 
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data from these CPETs (Mazzoleni et al 2016). The same dynamical systems model may be used 
for the estimation of VO2max using data from a submaximal effort independent of how different 
the responses differ between individuals.  Using data from a submaximal effort could potentially 
solve the issue of having to conduct a CPET with indirect calorimetry making it usable in many 
different setting where such equipment and testing specifics are not possible. Due to the 
prognostic value of VO2max in oncology, it is recommended that the results of using dynamical 
systems modeling prediction be tested accounting for reduced physiological capacity of patients 
(limiting exercise tolerability) which in turn would facilitate the use of estimated VO2max as 
another tool for physicians to inform best treatment practices in leukemia patients as well as in 
other cancer populations. Further research is needed to deduce what factors are limiting these 
patients from achieving higher VO2 values, and how we can train these individuals to improve 
their VO2max.  
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Appendix I 
DYNAMICAL SYSTEM TIME SERIES PLOT 2 
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Appendix II 
DYNAMICAL SYSTEM TIME SERIES PLOT 2 
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Appendix III 
DYNAMICAL SYSTEM LINE OF IDENTITY PLOT  
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